The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 2, 2007, Pages 194-201

  Lu, Shao Ming ^a   Tong, Ning ^a   Gelbard, Harris A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Glutamate; Human immunodeficiency virus type 1 (HIV 1); Inflammation; Platelet activating factor; Striatum; Synaptic plasticity

Indexed keywords

PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; C57BL MOUSE; COMPARATIVE STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; MALE; MOUSE; PHYSIOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; PHOSPHOLIPIDS; PLATELET ACTIVATING FACTOR; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 34247481370     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-007-9064-4     Document Type: Article

References (37)

1. Adle-Biassette H, Levy Y, Colombel M, Poron F, et al (1995) Neuronal apoptosis in HIV infection in adults, Neuropathol Appl Neurobiol 21:218-227
2. Bazan N (1998) The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog Brain Res 118:281-291
3. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC (2002) Control of synaptic strength by glial TNFalpha, Science 295:2282-2285
4. Bellizzi M, Lu S-M, Masliah E, Gelbard H (2005) Synaptic activity becomes excitotoxic in neurons exposed to elevated level of platelet-activating factor. J Clin Invest 115:3185-3192
5. Bennett S, Chen J, Pappas B, Roberts D, et al (1998) Platelet activating factor receptor expression is associated with neuronal apoptosis in an in vivo model of excitotoxicity. Cell Death Differ 5:867-875
6. Calabresi P, Maj R, Mercuri N, Bernardi G (1992) Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci Lett 142:95-99
7. Calabresi P, Picconi B, Saulle E, Centonze D, et al (2000) Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke 31:766-772 (discussion 773)
8. Charpier S, Deniau J (1997) In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc Natl Acad Sci U S A 94:7036-7040
9. Dawson VL, Dawson TM, Uhl GR, Snyder SH (1993) Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A 90:3256-3259
10. Dou H, Ellison B, Bradley J, Kasiyanov A, Xiong H, Dewhurst S, Gelbard HA, Gendelman HE (2005) Neuroprotective activities of lithium in murine HIV-1 encephalitis. J Neurosci 25(37):8375-8385
11. Fox H, Weed M, Huitron-Resendiz S, Baig J, et al (2000) Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106:37-45
12. Gelbard HA, Dzenko KA, DiLoreto D, del Cerro C, del Cerro M, Epstein LG (1993) Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 15:417-422
13. Gelbard H, Nottet H, Swindells S, Jett M, et al (1994) Platelet activating factor: a candidate HIV-1-induced neurotoxin. J Virol 68:4628-4635
14. Gelbard H, James H, Sharer L, Perry S, et al (1995) Identification of apoptotic neurons in post-mortem brain tissue with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 21:208-217
15. Gray F, Adle-Biassette H, Brion F, Ereau T, et al (2000) Neuronal apoptosis in human immunodeficiency virus infection. J Neurochem 6:S38-S43
16. Graybiel AM (1995) Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol 5:733-741
17. Kawaguchi Y, Wilson C, Emson P (1989) Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol 62:1052-1068
18. Kerr J, Wickens J (2001) Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J Neurophysiol 85:117-124
19. Kornecki E, Wieraszko A, Chan J, Ehrlich YH (1996) Platelet activating factor (PAF) in memory formation: role as a retrograde messenger in long-term potentiation. J Lipid Mediat Cell Signal 14:115-126
20. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-118
21. Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1993) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37:373-380
22. Mahon S, Casassus G, Mulle C, Charpier S (2003) Spike-dependent intrinsic plasticity increases firing probability in rat striatal neurons in vivo. J Physiol 550(3):947-959
23. O'Flaherty J, Redman J, Jr., Schmitt J, Ellis J, et al (1987) 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor. Biochem Biophys Res Commun 147:18-24
24. Partridge J, Tang K, Lovinger D (2000) Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 84:1422-1429
25. Perry S, Dbaibo G, Dzenko K, Epstein L, et al (1998) Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J Biol Chem 273:17660-17664
26. Petito C, Roberts B (1995) Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 146:1121-11230
27. Pettorossi V, Grassi S (2001) Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. Acta Otolaryngol Suppl 545: 160-165
28. Pisani A, Bonsi P, Centonze D, Calabresi P, et al (2000) Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons, J Neurosci 20:RC69
29. Plenz D, Kitai S (1998) Up and down states in striatal medium spiny neurons simultaneously recorded with spontaneous activity in fast-spiking interneurons studied in cortex-striatum-substantia nigra organotypic cultures. J Neurosci 18:266-283
30. Smith R, Musleh W, Akopian G, Buckwalter G, et al (2001) Regional differences in the expression of corticostriatal synaptic plasticity. Neuroscience 106:95-101
31. Spencer J, Murphy K (2000) Bi-directional changes in synaptic plasticity induced at corticostriatal synapses in vitro. Exp Brain Res 135:497-503
32. Tang K, Lovinger D (2000) Role of pertussis toxin-sensitive G
33. -proteins in synaptic transmission and plasticity at corticostriatal synapses. J Neurophysiol 83:60-69
34. Tong N, Sanchez J, Maggirwar S, Ramirez S, et al (2001) Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 13:1913-1922
35. Uhl E, Pickelmann S, Baethmann A, Schurer L (1999) Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. Stroke 30:873-879 (discussion 886)
36. Wieraszko A, Li G, Kornecki E, Hogan MV, Ehrlich YH (1993) Longterm potentiation in the hippocampus induced by platelet activating factor. Neuron 10:553-557
37. Zink W, Anderson E, Boyle J, Hock L, et al (2002) Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci 22:2096-2105